Purchase Order N6264519P0058
Award Date
10/1/19
Potential Completion Date
9/30/24
Potential Value
$3.3M
Federal Agency
Defense Health Agency
Awardee
Prolacta Bioscience, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bassett, CA 91746, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Prolacta Bioscience, Inc., a for-profit manufacturer of goods, has been awarded a Blanket Purchase Agreement (BPA) Call contract by the Defense Health Agency (DHA) to provide a variety of human milk-based nutritional products, including donor human milk, pre-natal formulas, breastmilk, and supplements, to support premature and critically ill infants in military medical facilities. The contract, valued at $18,091.00, has a firm fixed price pricing type and a completion date of September 30, 2024....
This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for $148,924.00. The contract is for PROLACT + 6, 30 ML 93901-30, which are human milk-based nutritional products for critically ill, premature infants in the neonatal intensive care unit (NICU). The contract has a period of performance from February 8, 2016 to February 7, 2017 and is designated as a Total Small Business set-aside. Prolacta Bioscience, a for-profit manufacturer,...
This federal contract award was issued by the U.S. Army Medical Command to Prolacta Bioscience, Inc., doing business as Prolacta Bioscience, a for-profit manufacturer of human milk-based nutritional products. The $351,630.75 firm fixed price delivery order is for "Fortified Human Breast Milk" and has an ultimate completion date of October 31, 2017. The contract is not set aside. Prolacta Bioscience has been awarded multiple prime contracts, primarily from the Defense Health Agency...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. to purchase Prolacta's human milk-based nutritional products for premature infants in military medical facilities. The contract has a total ceiling value of $24,838.69 and a period of performance through September 30, 2024. Prolacta Bioscience is a for-profit manufacturer that specializes in providing human milk-based products to support the care of...
This contract was awarded to Prolacta Bioscience, Inc. by the Department of the Army Medical Command. The contract, valued at $150,000.00, is for the provision of human milk-based neonatal nutrition products to support premature and critically ill infants treated at military medical facilities. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type, and a performance period ending on September 30, 2022. Prolacta Bioscience, a manufacturer of goods, has...
Prolacta Bioscience, Inc., a for-profit manufacturer of goods, has been awarded a Blanket Purchase Agreement (BPA) Call contract from the Defense Health Agency (DHA) to provide breastmilk supplementation products for neonatal intensive care unit (NICU) patients. The $13,022.86 firm fixed price contract has a performance period through September 30, 2024. Prolacta Bioscience, which holds two active indefinite delivery vehicles with the DHA valued at up to $250,000 and $1.75 million, delivers a...
This firm fixed price contract was awarded by the Defense Health Agency to Prolacta Bioscience, Inc. to provide Prolacta's proprietary human milk-based nutritional products for use with infants in the neonatal intensive care unit (NICU) at Tripler Army Medical Center. The $15,536.12 contract is a call against a larger $250,000 single-award blanket purchase agreement for donor human milk and a $1.75 million single-award BPA for various human milk-based products to support military treatment...
This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for the purchase of human milk-based breastmilk fortifiers for premature infants in the Neonatal Intensive Care Unit (NICU) at Tripler Army Medical Center. The contract has a ceiling value of $24,838.83 and a period of performance through September 30, 2025. Prolacta Bioscience is a for-profit manufacturer of human milk-based nutritional products for...
This is a firm fixed price blanket purchase agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Prolacta Bioscience, Inc. for the provision of breastmilk fortification products for use in neonatal intensive care units (NICUs). The contract has a ceiling value of $24,838.83 and a performance period through September 30, 2025. No set-aside was used for this award. Prolacta Bioscience is a for-profit manufacturer that specializes in human milk-based nutritional products...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Subsistence to Anham FZCO, a for-profit limited liability company based in the United Arab Emirates. The firm fixed-price delivery order is for the supply of milk and has a total ceiling value of $2,452.86. The contract was awarded on April 18, 2018 with a period of performance through May 1, 2018. This award is part of a larger Indefinite Delivery Contract (IDC) held by Anham FZCO to provide premium...